Creative Medical Technology Holdings, Inc. CELZ
Set alert
0.66 USD -0.02 -3.45%
At close · Oct 30
0.66 +0.01 +0.92%
After hours · Oct 30, 6:22 PM ET
0.655 Day range 0.719
0.6542 52-week range 3.28
- YTD
- -66.58%
- 1 year
- -79.97%
- Open
- 0.719
- Prev close
- 0.6784
- Mkt cap
- 4.97M
- Vol
- 87.32K
- Avg vol
- 6.75M
- EPS
- -2.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.655
- High
- 0.719
- Forward P/E
- -0.84
- Beta
- 0.00
- Short ratio
- 0.56
- Inst. own
- 3.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 3.08
- 200-d avg
- 3.82
- 1y target
- 30.00
2Y chart
Events in this range
- Nov 8, 2024Earnings: -0.75; estimate -0.85; surprise 11.76%
Signals (68)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| RSI: Oversold | Jul 31, 2026 | 3 months ago |
| RSI: Oversold | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| RSI: Oversold | Jul 13, 2026 | 3 months ago |
| RSI: Oversold | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| RSI: Overbought | Apr 17, 2026 | 6 months ago |
| SMA: Bullish | Mar 26, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 24, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 18, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 5, 2026 | 8 months ago |
| RSI: Oversold | Dec 30, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 12, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| RSI: Overbought | Oct 24, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 14, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 8, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Oct 2, 2025 | 1 year ago |
| SMA: Bullish | Sep 25, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 22, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 9, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 20, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 15, 2025 | 1 year ago |
| RSI: Overbought | Aug 6, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| RSI: Overbought | Jul 9, 2025 | 1 year ago |
| RSI: Overbought | Jun 26, 2025 | 1 year ago |
| SMA: Bullish | May 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Mar 12, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 6, 2025 | 1 year ago |
| RSI: Overbought | Mar 5, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 4, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 27, 2025 | 1 year ago |
| RSI: Overbought | Feb 12, 2025 | 1 year ago |
| RSI: Overbought | Feb 7, 2025 | 1 year ago |
| RSI: Overbought | Feb 4, 2025 | 1 year ago |
| RSI: Overbought | Jan 28, 2025 | 1 year ago |
| SMA: Bullish | Jan 24, 2025 | 1 year ago |
| SMA: Bearish | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 22, 2025 | 1 year ago |
Key statistics
- Market cap
- 3.79M
- Enterprise value
- -2.63M
- Trailing P/E
- 0.00
- Forward P/E
- -0.84
- PEG ratio
- 0.00
- Price / sales
- 344.80
- Price / book
- 0.44
- EPS (TTM)
- -3.80
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 11.00K
- Revenue growth
- 0.00%
- Free cash flow
- -3.66M
- Total cash
- 6.26M
- Total debt
- 14.19K
- Return on equity
- -57.03%
- Shares outstanding
- 1.75M
- Short % of float
- 1.75%
- 50-day average
- 3.08
- 200-day average
- 3.82
Analyst view
Consensus: none
Price target (mean) 30.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 9, 2024
Expected Aug 9, 2024. Consensus EPS estimate -0.63.
Financials — quick view
CELZ Revenue — quarterly 0
CELZ Net income — quarterly -1.51M
CELZ EPS — quarterly -0.41
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 8, 2024 | Sep 1, 2024 | -0.85 | -0.75 | +0.10 | +11.76% |
| Aug 9, 2024 | Jun 1, 2024 | -0.84 | -1.11 | -0.27 | -32.14% |
| Aug 9, 2024 | Jun 1, 2024 | -0.84 | — | — | — |
| May 10, 2024 | Mar 1, 2024 | -1.15 | — | — | — |
| May 10, 2024 | Mar 1, 2024 | -1.15 | -0.73 | +0.42 | +36.52% |
| Mar 22, 2024 | Dec 1, 2023 | -1.13 | — | — | — |
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- creativemedicaltechnology.com
News
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Creative Medical Technology Highlights Ultrasome Data Showing 93% Response Rate, 65% Pain Reduction In Knee Osteoarthritis Study
- Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
- Head to Head Analysis: Creative Medical Technology (NASDAQ:CELZ) versus Grifols (NASDAQ:GRFS)
- Creative Medical Technology Acquires 4M Additional BioDefense Stock For $200K Cash And 1M Shares, Raising Ownership To 80%
- Creative Medical Technology (NASDAQ:CELZ) & argenex (NASDAQ:ARGX) Head to Head Analysis
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Creative Medical Technology Announces Filing Of New US Provisional Patent Application To Expand IP Protection Surrounding Ultrasome, Its Proprietary Cell-Free Regenerative Medicine Platform
- Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
Your note
Sign in to keep a note on CELZ — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| WARBINGTON TIMOTHY | Chief Executive Officer | Purchase | Jun 27, 2023 | 34,904 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Aaron Wealth Advisors | 1.12% | 19,570 | 42.47K | Sep 29, 2024 |
| Vanguard Group Inc | 1.01% | 17,629 | 38.25K | Sep 29, 2024 |
| Two Sigma Advisers, LP | 0.83% | 14,500 | 31.46K | Sep 29, 2024 |
| Two Sigma Investments, LP | 0.75% | 13,106 | 28.44K | Sep 29, 2024 |
| UBS Group AG | 0.16% | 2,725 | 5.91K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.08% | 1,403 | 3.04K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.01% | 17,629 | 38.25K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.41% | 7,105 | 15.42K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.09% | 1,551 | 3.37K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.08% | 1,441 | 3.13K | Oct 30, 2024 |